June 2017 - Page 15 of 33 - BioLegacy Research

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-seattle-genetics.jpg" NAME"More Deaths Lead Seattle Genetics to Discontinue Phase III Leukemia Study" ALT"More Deaths Lead Seattle Genetics to Discontinue Phase III Leukemia Study"June 19, 2017By Alex Keown, BioSpace.com... Source:…

GeoVax Labs Inc. Awarded NIH Grant For Zika Vaccine

Post author:Sam
Post published:June 18, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Warning: These Could be the Top 3 Most Overrated Biotech Stocks

Post author:Sam
Post published:June 18, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Warning: These Could be the Top 3 Most Overrated Biotech Stocks" ALT"Warning: These Could be the Top 3 Most Overrated Biotech Stocks"June 19, 2017By Mark Terry, BioSpace.com Breaking…

Elsevier Launches Solution To Accelerate Drug Discovery Through Comprehensive Prediction And Assessment Of Drug-Drug Interactions

Post author:Sam
Post published:June 18, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

FDA’s Generic Drugs Office Passes Last Year’s Record for ANDAs Received

Post author:Sam
Post published:June 16, 2017
Post category:Drug Industry Daily

Two-thirds of the way through fiscal year 2017, the FDA has received at least 877 ANDAs, passing fiscal 2016’s total of 852 and beating fiscal 2015’s total by more than…

FDA Proposes Study to Improve DTC Print Ad Disclosures

Post author:Sam
Post published:June 16, 2017
Post category:Drug Industry Daily

The FDA is proposing an experimental study to examine the effects of risk disclosures and fine print in direct-to-consumer drug advertising. Source: Drug Industry Daily